Abstract
This chapter focuses on Integrative and Complementary Medicine (ICM) treatments with plausible mechanisms of action, supported by evidence of safety and efficacy in clinical trials. The key mental illness disorders covered included: mood, anxiety, stress-related, trauma, sleep, psychotic disorders, attention and hyperactivity disorder, and neurocognitive disorders. The major interventions covered include herbal and nutritional medicines, mind-body approaches (e.g., yoga, tai chi, qigong, breathwork), and acupuncture. All of the interventions discussed have relatively low side-effect profiles and high margins of safety, particularly when compared to prescription medications. There is reason to believe that certain herbal and nutraceutical agents exert significant neurobiological effects, in addition to supporting healthier functioning of the nervous system. Although some valuable ICM treatments have not been generally used by physicians in the United States or approved for specific indications by the FDA, based on the available evidence of safety and efficacy, they are well worth consideration by clinicians who want to explore more options for improving their patients’ health and wellbeing. Clinicians need to be mindful of differences in quality and standardization among supplements produced by different companies. Further, in clinical practice, it may require several trials to design effective integrative treatments. A well-informed clinician is best qualified to help patients and families develop a safe, evidence-based integrative treatment plan.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbot, R., Chang, D. D., Eyre, H., & Lavretsky, H. (2017). Mind-body practices Tai Chi and Qigong in the treatment and prevention of psychiatric disorders. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 261–279). American Psychiatric Association Publishing.
Abbott, R., & Lavretsky, H. (2013). Tai Chi and Qigong for the treatment and prevention of mental disorders. Psychiatric Clinics of North America, 36(1), 109–120.
Afshar, H., Roohafza, H., et al. (2012). N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 32(6), 797–803.
Akhondzadeh, S., & Abbasi, S. H. (2006). Herbal medicine in the treatment of Alzheimer’s disease. American Journal of Alzheimer’s Disease and Other Dementias, 21, 113–118.
Akhondzadeh, S., Naghavi, H. R., Vazirian, M., et al. (2001). Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. Journal of Clinical Pharmacy and Therapeutics, 26, 363–367.
Akhondzadeh, S., Noroozian, M., Mohammadi, M., et al. (2003). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomised, placebo-controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry, 74(7), 863–866.
Akhondzadeh, S., Fallah-Pour, H., Afkham, K., et al. (2004a). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial. BMC Complementary and Alternative Medicine, 4, 12.
Akhondzadeh, S., Mohammadi, M. R., & Khademi, M. (2004b). Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial. BMC Psychiatry, 4, 9.
Akhondzadeh, S., Tahmacebi-Pour, N., Noorbala, A. A., et al. (2005). Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo-controlled trial. Phytotherapy Research, 19, 148–151.
Akhondzadeh, B., Moshiri, E., et al. (2007). Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(2), 439–442.
Akhondzadeh, S., Sabet, M. S., Harirchian, M. H., et al. (2010). Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: A 16-week, randomized and placebo-controlled trial. Journal of Clinical Pharmacology and Therapeutics, 35, 581–588.
Akhondzadeh, S., Brown, R. P., & Gerbarg, P. L. (2013). Nutrients for prevention and treatment of mental health disorders. Psychiatric Clinics of North America, 36(1), 25–36.
Almeida, J. C., & Grimsley, E. W. (1996). Coma from the health food store: Interaction between kava and alprazolam. Annals of Internal Medicine, 125, 940–941.
Amaducci, L. (1988). Phosphatidylserine in the treatment of Alzheimer’s disease: Results of a multicenter study. Psychopharmacology Bulletin, 24, 130–134.
American Psychiatric Association. (2015). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Press.
Amminger, G. P., Schafer, M. R., Papageorgiou, K., et al. (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry, 67(2), 146–154.
Amminger, G. P., Nelson, B., Markulev, C., et al. (2020). The NEURAPRO biomarker analysis: Long-chain Omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis. Biological Psychiatry, 87(3), 243–252.
Amsterdam, J. D., Li, Y., et al. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology, 29(4), 378–382.
Antalis, C. J., Stevens, L. J., Campbell, M., et al. (2006). Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 75, 299–308.
Appel, K., Rose, T., Fiebich, B., et al. (2011). Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytotherapy Research, 25(6), 838–843.
Arendt, J. (1997). Jet lag/night shift, blindness and melatonin. Transactions of the Medical Society of London, 114, 7–9.
Arnold, L. E., Amato, A., et al. (2007). Acetyl-l-carnitine (ALC) in attention-deficit/hyperactivity disorder: A multi-site, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 17(6), 791–801.
Arnold, L. E., Disilvestro, R. A., & Bozzolo, D. (2011). Zinc for attention-deficit/hyperactivity disorder: Placebo-controlled double-blind pilot trial alone and combined with amphetamine. Journal of Child and Adolescent Psychopharmacology, 1(1), 1–19.
Awad, R., Levac, D., et al. (2007). Effects of traditionally used anxiolytic botanicals on enzymes of the γ-aminobutyric acid (GABA) system. Canadian Journal of Physiology & Pharmacology, 85(9), 933–942.
Ballard, C. G., O’Brien, J. T., Reichelt, K., et al. (2002). Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. Journal of Clinical Psychiatry, 63(7), 553–558.
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., et al. (2007). Dietary patterns and risk of dementia: The Three-City cohort study. Neurology, 69(20), 1921–1930.
Beauregard, M., & Levesque, J. (2006). Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 31(1), 3–20.
Bell, I. R., Morrow, F. D., Read, M., et al. (1992). Low thyroxine levels in female psychiatric inpatients with riboflavin deficiency: Implications for folate-dependent methylation. Acta Psychiatrica Scandinavica, 85, 360–363.
Bellon, A. (2006). Searching for new options for treating insomnia: Are melatonin and ramelteon beneficial? Journal of Psychiatric Practice, 12, 229–243.
Bender, K. J. (2000). Investigating inositol in psychiatry. Psychiatric Times, 41–46.
Benjamin, J., Agam, G., Levine, J., et al. (1995a). Inositol treatment in psychiatry. Psychopharmacology Bulletin, 31, 167–175.
Benjamin, J., Levine, J., Fux, M., et al. (1995b). Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. American Journal of Psychiatry, 152, 1084–1086.
Benke, D., Barberis, A., Kopp, S., et al. (2009). GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 56(1), 174–181.
Benson, H., Malhotra, M. S., Goldman, R. F., et al. (1990). Three case reports of the metabolic and electroencephalographic changes during advanced Buddhist meditation techniques. Behavioral Medicine, 16, 90–95.
Bent, S., Padula, A., Moore, D., et al. (2006). Valerian for sleep: A systematic review and meta-analysis. American Journal of Medicine, 119(12), 1005–1012.
Benton, D., Haller, J., & Fordy, J. (1995). Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 32, 98–105.
Berger, G. E., Proffitt, T. M., McConchie, M., et al. (2007). Ethyl-eicosapentaenoic acid in first-episode psychosis: A randomized, placebo-controlled trial. Journal of Clinical Psychiatry, 68(12), 1867–1875.
Berk, M., Copolov, D., Dean, O., et al. (2008). N-Acetylcysteine as a glutathione precursor for schizophrenia – A double-blind, randomized, placebo-controlled trial. Biological Psychiatry, 64(5), 361–368.
Berk, M., Munib, A., Dean, O., et al. (2011). Qualitative methods in early-phase drug trials: Broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia. Journal of Clinical Psychiatry, 72(7), 909–913.
Bersani, G., & Garavini, A. (2000). Melatonin add-on in manic patients with treatment resistant insomnia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 24, 185–191.
Bhargav, H. (2020). Tele-yoga for stress management: Need of the hour during the COVID-19 pandemic and beyond? Asian Journal of Psychiatry, 54, 1–3.
Bhargav, H., George, S., Varambally, S., & Gangadhar, B. N. (2021a). Yoga and psychiatric disorders: A review of biomarker evidence. International Review of Psychiatry, 33(1–2), 162–169.
Bhargav, P. H., Reddy, P. V., Govindaraj, R., et al. (2021b). Impact of a course of add-on supervised yoga on cortical inhibition in major depressive disorder: A randomized controlled trial. The Canadian Journal of Psychiatry, 66(2), 179–181.
Bhatia, T., Agarwal, A., Shah, G., et al. (2012). Adjunctive cognitive remediation for schizophrenia using yoga: An open, non-randomized trial. Acta Neuropsychiatrica, 24, 91–100.
Biederman, J., & Faraone, S. V. (2005). Attention-deficit hyperactivity disorder. The Lancet, 366(9481), 237–248.
Bilici, M., Yildirim, F., Kandil, S., et al. (2004). Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28, 181–190.
Birch, E. E., Garfield, S., Hoffman, D. R., et al. (2000). A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine and Child Neurology, 42, 174–181.
Birdsall, T. C. (1998). 5-Hydroxytryptophan: A clinically effective serotonin precursor. Alternative Medicine Review, 3(4), 271–280.
Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 50(10), 991–1000.
Blumenthal, M. (2017). Issues in phytomedicine related to psychiatric practice. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 105–112). American Psychiatric Association Publishing.
Bottiglieri, T. (2013). Folate, vitamin B12, and S-adenosylmethionine. Psychiatric Clinics of North America, 36(1), 1–14.
Bottiglieri, T., Gerbarg, P. L., & Brown, R. P. (2017). S-Adenosylmethionine. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 41–52). American Psychiatric Association Publishing.
Bourre, J. M. (2005). Dietary omega-3 fatty acids and psychiatry: Mood, behaviour, stress, depression, dementia and aging. Journal of Nutrition, Health and Aging, 9, 31–38.
Bourre, J. M. (2006). Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 2. Macronutrients. Journal of Nutrition Health and Aging, 10, 386–399.
Boutron, I., Altman, D. G., Moher, D., for the CONSORT NPT Group, et al. (2017). CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial. Annals of Internal Medicine, 167, 40–47.
Brown, R. P., & Garbarg, P. L. (2004). The Rhodiola revolution. Rodale Press.
Brown, R. P., & Gerbarg, P. L. (2005). Sudarshan Kriya yoga breathing in the treatment of stress, anxiety, and depression: Part I–Neurophysiological model. Journal of Complementary and Alternative Medicine, 11, 189–201.
Brown, R. P., & Gerbarg, P. L. (2009). Yoga breathing, meditation, and longevity. Annals of the New York Academy of Sciences, 1172, 54–62.
Brown, R. P., & Gerbarg, P. L. (2011). Complementary and integrative treatments in brain injury. In J. M. Silver, T. W. McAllister, & S. C. Yudofsky (Eds.), Textbook of traumatic brain injury (2nd ed., pp. 599–622). American Psychiatric Publishing.
Brown, R. P., & Gerbarg, P. L. (2012a). Non-drug treatments for ADHD: New options for kids, adults, and clinicians. W.W. Norton.
Brown, R. P., & Gerbarg, P. L. (2012b). The healing power of the breath: Simple techniques to reduce stress and anxiety, enhance concentration, and balance your emotions. Shambhala Publications.
Brown, R. P., & Gerbarg, P. L. (2017). Breathing techniques in psychiatric treatment. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 241–250). American Psychiatric Association Publishing.
Brown, R. P., Gerbarg, P. L., & Bottiglieri, T. (2000). S-adenosylmethionine (SAMe) in the clinical practice of psychiatry, neurology, and internal medicine. Clinical Practice of Alternative Medicine, 1(4), 230–241.
Brown, R. P., Gerbarg, P. L., & Ramazanov, Z. (2002). A phythomedicinal review of Rhodiola rosea. HerbalGram, 56, 40–62.
Brown, R. P., Gerbarg, P. L., & Muskin, P. R. (2009). How to use herbs, nutrients, and yoga in mental health care. W.W. Norton.
Brown, R. P., Gerbarg, P. L., & Muench, F. (2013). Breathing practices for treatment of psychiatric and stress-related medical conditions. Psychiatric Clinics of North America, 36(1), 121–140.
Burns, N. R., Bryan, J., & Nettelbeck, T. (2006). Ginkgo biloba: No robust effect on cognitive abilities or mood in healthy young or older adults. Human Psychopharmacology, 21, 27–37.
Businaro, R., Vauzour, D., Sarris, J., et al. (2021). Therapeutic opportunities for food supplements in neurodegenerative diseases and depression. Frontiers in Nutrition: Section Nutrition and Brain Health. (accepted).
Bussing, R., Zima, B. T., et al. (2002). Use of complementary and alternative medicine for symptoms of attention-deficit hyperactivity disorder. Psychiatric Services, 53(9), 1096–1102.
Cabyoglu, M. T., Ergene, N., et al. (2006). The mechanism of acupuncture and clinical applications. International Journal of Neuroscience, 116(2), 115–125.
Caffarra, C., & Santamaria, V. (1987). The effects of phosphatidylserine in patients with mild cognitive decline: An open trial. Clinical Trials Journal, 24, 109–111.
Cakici, N., Van Beveren, N., Judge-Hundal, G., et al. (2019). An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: A meta-analysis. Psychological Medicine, 49(14), 2307–2319.
Cardoso, B. R., Cominetti, C., & Cozzolino, S. M. F. (2013). Importance and management of micronutrient deficiencies in patients with Alzheimer disease. Clinical Interventions in Aging, 8, 531–542.
Carter, J., Gerbarg, P. L., Brown, R. P., et al. (2013). Multi-component yoga breath program for Vietnam veteran post-traumatic stress disorder: Randomized controlled trial. Journal of Traumatic Stress Disorders & Treatment, 2(3), 1–10.
Chalon, S. (2006). Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins, Leukottrienes, and Essential Fatty Acids, 75(4–5), 259–269.
Chan, E., Rappaport, L. A., et al. (2003). Complementary and alternative therapies in childhood attention and hyperactivity problems. Journal of Developmental and Behavioral Pediatrics, 24(1), 4–8.
Chang, J. P. C., Su, K.-P., Mondelli, V., et al. (2018). Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology, 43(3), 534–545.
Chen, E. Y., & Hui, C. L. (2012). HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: A double-blind, placebo-controlled study. Phytotherapy Research, 26(8), 1166–1172.
Chen, K. W., Berger, C. C., Manheimer, E., et al. (2012). Meditative therapies for reducing anxiety: A systematic review and meta-analysis of randomized controlled trials. Depression and Anxiety, 29(7), 545–562.
Chen, W. G., Schloesser, D., Arensdorf, A. M., et al. (2021). The emerging science of interoception: Sensing, integrating, interpreting, and regulating signals within the self. Trends in Neuroscience, 44(1), 3–16.
Chengappa, K. N. R., Brar, J. S., Gannon, J. M., et al. (2018). Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 79(5), 17m11826.
Clough, A. R., Bailie, R. S., & Currie, B. (2003). Liver function test abnormalities in users of aqueous kava extracts. Journal of Toxicology. Clinical Toxicology, 41, 821–829.
Conquer, J. A., Tierney, M. C., Zecevic, J., et al. (2000). Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids, 35, 1305–1312.
ConsumerLab.com. (2013). Product review: St. John’s Wort supplements review. https://www.consumerlab.com/reviews/St_Johns_Wort/stjohnswort/. Accessed 13 Jan 2014.
Coppen, A., & Bailey, J. (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo-controlled trial. Journal of Affective Disorders, 60, 121–130.
Cott, J. M. (2002). Herb-drug interactions: Focus on pharmacokinetics. CNS Spectrums, 6, 827–832.
Coulter, D. (2007). Assessment of the risk of hepatotoxicity with kava products. WHO Appointed Committee. World Health Organization.
Craig, A. D. (2008). Interoception and emotion. In M. Lewis, J. M. Haviland-Jones, & L. F. Barrett (Eds.), Handbook of emotions (3rd ed., pp. 272–288). Guilford Press.
Crook, T., Petrie, W., Wells, C., et al. (1992). Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacology Bulletin, 28, 61–66.
Czyrak, A., Rogoz, Z., Skuza, G., et al. (1992). Antidepressant activity of S-adenosyl-l-methionine in mice and rats. Journal of Basic and Clinical Physiology and Pharmacology, 3, 1–17.
Darbinyan, V. A., Aslanyan, G., Embroyan, E., et al. (2007). SHR-5 and the treatment of depression. Nordic Journal of Psychiatry, 61, 5.
Davidson, R. J., Kabat-Zinn, J., Schumacher, J., et al. (2003). Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine, 65(4), 564–570.
Dean, O. M., Bush, A., et al. (2012). Translating the Rosetta Stone of N-acetylcysteine. Biological Psychiatry, 71(11), 935–936.
Descilo, T., Vedamurthachar, A., Gerbarg, P. L., et al. (2010). Effects of a yoga-breath intervention alone and in combination with an exposure therapy for PTSD and depression in survivors of the 2004 Southeast Asia tsunami. Acta Psychiatrica Scandinavica, 121(4), 289–300.
Di Rocco, A., Rogers, J. D., Brown, R., et al. (2000). S-Adenosyl-methionine improves depression in patients with Parkinson’s disease in an open-label clinical trial. Movement Disorders, 15(6), 1225–1229.
Diamond, B. J., & Bailey, M. R. (2013). Ginkgo biloba indications, mechanisms, and safety. Psychiatric Clinics of North America, 36(1), 73–83.
Dodd, S., Maes, M., Anderson, G., et al. (2013). Putative neuroprotective agents in neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, 135–145.
Donath, F., Quispe, S., Diefenbach, K., et al. (2000). Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 33, 47–53.
Dowling, G. A., Mastick, J., Colling, E., et al. (2005). Melatonin for sleep disturbances in Parkinson’s disease. Sleep Medicine, 6, 459–466.
Dubichev, A. G., Kurkin, B. A., Zapesochnaya, G. G., et al. (1991). Study of Rhodiola rosea root chemical composition using HPLC. Chemico-Pharmaceutical Journal, 2, 188–193.
Duraiswamy, G., Thirthalli, J., Nagendra, H. R., et al. (2007). Yoga therapy as an add-on treatment in the management of patients with schizophrenia: A randomized controlled trial. Acta Psychiatrica Scandinavica, 116, 226–232.
Ernst, E. (2002). The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s wort, ginseng, Echinacea, saw palmetto, and kava. Annals of Internal Medicine, 136, 42–53.
Errington-Evans, N. (2012). Acupuncture for anxiety. CNS Neuroscience and Therapeutics, 18(4), 277–284.
Farah, A. (2009). The role of L-methylfolate in depressive disorders. CNS Spectrums, 14(1 Suppl 2), 2–7.
Fava, M., Rosenbaum, J. F., Birnbaum, R., et al. (1992). The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients. Acta Psychiatrica Scandinavica, 86, 42–45.
Fava, M., Borus, J. S., Alpert, J. E., et al. (1997). Folate, vitamin B12, and homocysteine in major depressive disorder. American Journal of Psychiatry, 154(3), 426–428.
FDA. (2002). Kava-containing dietary supplements may be associated with severe liver injury. US Food and Drug Administration Center for Food Safety and Applied Nutrition. http://www.fda.gov/food/resourcesforyou/consumers/ucm085482.htm. Accessed 13 Jan 2014.
Fehmi, L. G., Edward, E. T., & Shor, S. B. (2017). Open focus training for stress, pain, and psychosomatic illness. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 293–304). American Psychiatric Association Publishing.
Fernández-San-Martín, M. I., Masa-Font, R., Palacios-Soler, L., et al. (2010). Effectiveness of valerian on insomnia: A meta-analysis of randomized placebo-controlled trials. Sleep Medicine, 11(6), 505–511.
Feuerstein, G. (1998). The yoga tradition: Its history, literature, philosophy and practice. Hohm Press.
Firth, J., Teasdale, S. B., Allott, K., et al. (2019). The efficacy and safety of nutrient supplements in the treatment of mental illness: A meta-synthesis and appraisal of 33 meta-analyses of randomized controlled trials. World Psychiatry, 18(3), 308–324.
Fonkoue, I. T., Hu, Y., Jones, T., et al. (2020). Eight weeks of device-guided slow breathing decreases sympathetic nervous reactivity to stress in posttraumatic stress disorder. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 319(4), R466–R475.
Freund-Levi, Y., Eriksdotter-Jonhagen, M., Cederholm, T., et al. (2006). Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Archives of Neurology, 63, 1402–1408.
Fusar-Poli, P., & Berger, G. (2012). Eicosapentaenoic acid interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled studies. Journal of Clinical Psychopharmacology, 32(2), 179–185.
Fux, M., Levine, J., Aviv, A., et al. (1996). Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 153(9), 1219–1221.
Gannon, J. M., Brar, J., Rai, A., et al. (2019). Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial. Annals of Clinical Psychiatry, 31(2), 123–129.
Gelenberg, A. J. (2000). St. John’s wort update. Biological Therapies in Psychiatry, 23, 22–24.
Gerbarg, P. L., & Brown, R. P. (2013). Phytomedicines for prevention and treatment of mental health disorders. Psychiatric Clinics of North America, 36(1), 37–48.
Gerbarg, P. L., & Brown, R. P. (2016a). Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine, 23(9), 763–769.
Gerbarg, P. L., & Brown, R. P. (2016b). Neurobiology and neurophysiology of breath practices in psychiatric care. Psychiatric Times, 33(11), 22–25.
Gerbarg, P. L., & Brown, R. P. (2021). Non-western interventions for stress reduction and resilience. British Journal of Psychiatric Advances, 27(3), 198–200.
Gerbarg, P. L., Wallace, G., & Brown, R. P. (2011). Mass disasters and mind-body solutions: Evidence and field insights. International Journal of Yoga Therapy, 21, 97–107.
Gerbarg, P. L., Brown, R. P., & Muskin, P. R. (2017a). Complementary and integrative medicine, DSM-5, and clinical decision making. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 9–20). American Psychiatric Association Publishing.
Gerbarg, P. L., Muskin, P. R., & Brown, R. P. (Eds.). (2017b). Complementary and integrative treatments in psychiatric practice. American Psychiatric Association Publishing.
Gerbarg, P. L. & Brown, R. P. (2017c). Integrating Rhodiola rosea into Clinical Practice. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 135–141). American Psychiatric Association Publishing.
Gerbarg, P. L., Brown, R. P., Streeter, C. C., et al. (2019). Breath practices for survivor and caregiver stress, depression, and post-traumatic stress disorder: Connection, co-regulation, compassion. Integrative and Complementary Medicine OBM, 4(3), 1–24.
Gerbarg, P. L., Brown, R. P., Mansur, S., & Steidle, K. (2021). Survivors of mass disasters: Breath-based mind-body interventions and global platforms. In S. Okpaku (Ed.), Innovations in global mental health (pp. 1557–1579). Switzerland AG, Springer Nature.
Gooneratne, N. S. (2008). Complementary and alternative medicine for sleep disturbances in older adults. Clinics in Geriatric Medicine, 24(1), 121–138.
Govindaraj, R., Varambally, S., Rao, N. P., et al. (2020). Does Yoga have a role in schizophrenia management? Current Psychiatry Reports, 22(12), 78.
Granath, J., Ingvarsson, S., von Thiele, U., et al. (2006). Stress management: A randomized study of cognitive behavioural therapy and yoga. Cognitive Behaviour Therapy, 35, 3–10.
Grant, J. E., Odlaug, B. L., et al. (2009). N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Archives of General Psychiatry, 66(7), 756–763.
Grima, N. A., Pase, M. P., et al. (2012). The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. Journal of Alzheimer’s Disease, 29(3), 561–569.
Guu, T. W., Mischoulon, D., Sarris, J., et al. (2020). A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders, 265, 233–238.
Haffner, J., Roos, J., Goldstein, N., et al. (2006). The effectiveness of body oriented methods of therapy in the treatment of attention-deficit hyperactivity disorder (ADHD): Results of a controlled pilot study. Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie, 34, 37–47. (in German).
Hebert, R., Lehmann, D., Tan, G., et al. (2005). Enhanced EEG alpha time domain phase synchrony during transcendental meditation: Implications for cortical integration theory. Signal Processing, 85(11), 2213–2232.
Helgason, C., & Sarris, J. (2013). Mind-body medicine for schizophrenia and psychotic disorders. Clinical Schizophrenia and Related Psychoses, 7(3), 138–148.
Heresco-Levy, U., Javitt, D., Ermilov, M., et al. (1999). Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Archives of General Psychiatry, 56, 29–36.
Herrera-Arellano, A., Jiménez-Ferrer, E., et al. (2007). Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam. Planta Medica, 73(8), 713–717.
Herrera-Arellano, A., Jiménez-Ferrer, J. E., et al. (2012). Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial. Planta Medica, 78(14), 1529–1535.
Herrero, J. L., Khuvis, S., & Mehta, A. D. (2017). Breathing above the brainstem: Volitional control and attentional modulation in humans. Journal of Neurophysiology, 119(1), 145–159.
Herrschaft, H., Nacu, A., & Likhachev, S. (2012). Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Journal of Psychiatric Research, 46(6), 716–723.
Hibbeln, J. R. (1998). Fish consumption and major depression. The Lancet, 351(9110), 1213.
Hirayama, S., Hamazaki, T., et al. (2004). Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – A placebo-controlled double-blind study. European Journal of Clinical Nutrition, 58(3), 467–473.
Hirayama, S., Terasawa, K., Rabeler, R., et al. (2013). The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: A randomised, double-blind, placebo-controlled clinical trial. Journal of Human Nutrition and Dietetics Suppl. 2:284–291.
Holtmann, M., & Stadler, C. (2006). Electroencephalographic biofeedback for the treatment of attention-deficit hyperactivity disorder in childhood and adolescence. Expert Review of Neurotherapeutics, 6, 533–540.
Hopper, J. W., Frewen, P. A., van der Kolk, B. A., et al. (2007). Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: Symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery. Journal of Traumatic Stress, 20(5), 713–725.
Hosseinzadeh, H., & Noraei, N. B. (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytotherapy Research, 23(6), 768–774.
Hourani, L. L., Davila, M. I., Morgan, J., et al. (2019). Mental health, stress, and resilience correlates of heart rate variability among military reservists, guardsmen, and first responders. Physiology and Behavior, 1(214), 112734.
Howes, M. J., & Perry, E. (2011). The role of phytochemicals in the treatment and prevention of dementia. Drugs and Aging, 28(6), 439–468.
Hsu, S.-M., Tseng, C.-H., Hsieh, C.-H., et al. (2020). Slow-paced inspiration regularizes alpha phase dynamics in the human brain. Journal of Neurophysiology, 123(1), 289–299.
Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St. John’s wort) in major depressive disorder: A randomized controlled trial. JAMA, 287(14), 1807–1814.
Iwasaki, K., Satoh-Nakagawa, T., & Maruyama, M. (2005). A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. The Journal of Clinical Psychiatry, 66(2), 248–252.
Izzo, A. A. (2004). Drug interactions with St. John’s wort (Hypericum perforatum): A review of the clinical evidence. International Journal of Clinical Pharmacology and Therapeutics, 42(3), 139–148.
Jacobs, B. P., Bent, S., Tice, J. A., et al. (2005). An Internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore), 84, 197–207.
Jayaram, N., Varambally, S., Behere, R. V., et al. (2013). Effect of yoga therapy on plasma oxytocin and facial emotion recognition deficits in patients of schizophrenia. Indian Journal of Psychiatry, 55(Suppl 3), S409–S413.
Jensen, P. S., & Kenny, D. T. (2004). The effects of yoga on the attention and behavior of boys with attention-deficit/hyperactivity disorder (ADHD). Journal of Attention Disorders, 7, 205–216.
Jensen, C. L., Chen, H., Fraley, J. K., et al. (1996). Biochemical effects of dietary linoleic/alpha-linolenic acid ratio in term infants. Lipids, 31, 107–113.
Jiménez-Ferrer, E., Herrera-Ruiz, M., et al. (2011). Interaction of the natural anxiolytic galphimine-B with serotonergic drugs on dorsal hippocampus in rats. Journal of Ethnopharmacology, 137(1), 724–729.
Kabat-Zinn, J., Massion, A. O., Kristeller, J., et al. (1992). Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. American Journal of Psychiatry, 149(7), 936–943.
Kalyani, B. G., Venkatasubramanian, G., Arasappa, R., et al. (2011). Neurohemodynamic correlates of ‘OM’ chanting: A pilot functional magnetic resonance imaging study. International Journal of Yoga, 4(1), 3–6.
Katsumoto, E., Ishida, T., Kinoshita, K., et al. (2021). Yokukansankachimpihange is useful to treat behavioral/psychological symptoms of dementia. Frontiers in Nutrition, 7, 529390.
Katzman, M. A., Vermani, M., Gerbarg, P. L., et al. (2012). A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from Generalized Anxiety Disorder (GAD) with or without comorbidities. International Journal of Yoga, 5(1), 57–65.
Kayumov, L., Brown, G., Jindal, R., et al. (2001). A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosomatic Medicine, 63, 40–48.
Keefe, J. R., Mao, J. J., Soeller, I., et al. (2016). Short-term open-label chamomile (Matricaria chamomilla L) therapy of moderate to severe generalized anxiety disorder. Phytomedicine, 23, 1699–1705.
Kennedy, D. O., & Scholey, A. B. (2006). The psychopharmacology of European herbs with cognition-enhancing properties. Current Pharmacuetical Design, 12(35), 4613–4623.
Kennedy, D. O., Wake, G., Savelev, S., et al. (2003). Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology, 28, 1871–1881.
Kennedy, D. O., Little, W., & Scholey, A. B. (2004). Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (lemon balm). Psychosomatic Medicine, 66, 607–613.
Kennedy, D. O., Pace, S., Haskell, C., et al. (2006). Effects of cholinesterase inhibiting sage (Salvia officinalis) in mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology, 31(4), 845–852.
Kennedy, D. O., Dodd, F. L., Robertson, B. C., et al. (2011). Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. Journal of Psychopharmacology, 25(8), 1088–1100.
Kenny, E., Muskin, P. R., Brown, R., et al. (2001). What the general psychiatrist should know about herbal medicine. Current Psychiatry Reports, 3, 226–234.
Kidd, P. M. (2000). Attention deficit/hyperactivity disorder (ADHD) in children: Rationale for its integrative management. Alternative Medicine Review, 5, 402–428.
Kim, H. J., Kim, P., & Shin, C. Y. (2013). A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. Journal of Ginseng Research, 37(1), 8–29.
Knüppel, L., & Linde, K. (2004). Adverse effects of St. John’s wort: A systematic review. Journal of Clinical Psychiatry, 65, 1470–1479.
Ko, R. J. (1998). Adulterants in Asian patent medicines. New England Journal of Medicine, 339, 847.
Konofal, E., Lecendreux, M., et al. (2008). Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatric Neurology, 38(1), 20–26.
Kraft, M., Spahn, T. W., Menzel, J., et al. (2001). Fulminant liver failure after administration of the herbal antidepressant kava-kava. Deutsche Medizinische Wochenschrift, 126, 970–972. (in German).
Kris-Etherton, P. M., Harris, W. S., Appel, L. J., & for the Nutrition Committee. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747–2757.
Kwon, C.-Y., & Lee, B. (2021). Herbal medicine for behavioral and psychological symptoms of dementia: A systematic review and meta-analysis. Frontiers in Pharmacology, 12, 713287.
Kyle, D. J., Schaefer, E., & Patton, G. (1998). Low serum docosahexanoic acid is a significant risk factor for Alzheimer’s dementia. Presented at the 3rd ISSFAL Congress, 1–5 June 1998, Lyon.
Lake, J., Helgason, C., & Sarris, J. (2012). Integrative mental health (IMH): Paradigm, research, and clinical practice. Explore (New York, N.Y.), 8(1), 50–57.
LaPorte, E., Sarris, J., et al. (2011). Neurocognitive effects of kava (Piper methysticum): A systematic review. Human Psychopharmacology, 26(2), 102–111.
Larsen, S. (2006). The healing power of neurofeedback. The Healing Press.
Lautenschlager, N. T., Ihl, R., et al. (2012). Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer’s disease: A research perspective. International Psychogeriatrics, 24(Suppl 1), S46–S50.
Lavretsky, H., & Feldman, J. L. (2021). Precision medicine for breath-focused mind-body therapies for stress and anxiety: Are we ready yet? Global Advances in Health and Medicine, 10, 1–4.
Lazar, S. W., Kerr, C. E., Wasserman, R. H., et al. (2005). Meditation experience is associated with increased cortical thickness. Neuroreport, 16, 1893–1897.
Le Bars, P. L., Velasco, F. M., Ferguson, J. M., et al. (2002). Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer’s disease. Neuropsychobiology, 45, 19–26.
Lee, M. S., Kim, M. K., & Lee, Y. H. (2005a). Effects of Qi-therapy (external Qigong) on cardiac autonomic tone: A randomized placebo-controlled study. International Journal of Neuroscience, 115(9), 1345–1350.
Lee, M. S., Rim, Y. H., Jeong, D. M., et al. (2005b). Nonlinear analysis of heart rate variability during Qi therapy (external Qigong). American Journal of Chinese Medicine, 33(4), 579–588.
Lehmann, D., Faber, P. L., Achermann, P., et al. (2001). Brain sources of EEG gamma frequency during volitionally meditation-induced, altered states of consciousness, and experience of the self. Psychiatry Research, 108, 111–121.
Lehrer, P., Karavidas, M. K., Lu, S. E., et al. (2010). Voluntarily produced increases in heart rate variability modulate autonomic effects of endotoxin induced systemic inflammation: An exploratory study. Applied Psychophysiology Biofeedback, 35(4), 303–315.
Lerner, V., Kanevsky, M., Dwolatzky, T., et al. (2006). Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clinical Nutrition, 25, 60–67.
Li, J. Y., Zhang, Y. F., Smith, G. S., et al. (2011a). Quality of reporting of randomized clinical trials in tai chi interventions – A systematic review. Evidence-based Complementary and Alternative Medicine, 2011, 383245.
Li, J. J., Li, Z. W., Wang, S. Z., et al. (2011b). Ningdong granule: A complementary and alternative therapy in the treatment of attentiondeficit/hyperactivity disorder. Psychopharmacology, 216(4), 501–509.
Linde, K., Ramirez, G., Mulrow, D. F., et al. (1996). St. John’s wort for depression – An overview and meta-analysis of randomized clinical trials. BMJ, 313(7052), 253–258.
Linde, K., Berner, M., et al. (2008). St John’s wort for major depression. Cochrane Database of Systematic Reviews, (4), CD000448.
Lutz, A., Greischar, L. L., Rawlings, N. B., et al. (2004). Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proceedings of the National Academy of Sciences of The United States of America, 101, 16369–16373.
Lyon, M. R., Cline, J. C., Totosy de Zepetnek, J., et al. (2001). Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: A pilot study. Journal of Psychiatry and Neuroscience, 26, 221–228.
Maciocia, G. (1994). The practice of Chinese medicine: The treatment of diseases with acupuncture and Chinese herbs. Churchill Livingstone.
Manjunath, N. K., & Telles, S. (2005). Influence of Yoga and Ayurveda on self rated sleep in a geriatric population. Indian Journal of Medical Research, 121, 683–690.
Mao, J. J., Xie, S. X., Keefe, J. R., et al. (2016). Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine, 23(14), 1735–1742.
Marchand, W. R. (2013). Mindfulness meditation practices as adjunctive treatments for psychiatric disorders. Psychiatric Clinics of North America, 36(1), 141–152.
Marx, W., Lane, M., Rocks, T., et al. (2019). Effect of saffron supplementation on symptoms of depression and anxiety: A systematic review and meta-analysis. Nutrition Review, 28, nuz023.
Mason, H., Gerbarg, P. L., & Brown, R. P. (2021). Psychophysiology: Healing effects of voluntarily regulated breathing practices. In S. Telles & R. K. Gupt (Eds.), Handbook of research on evidence-based perspectives on the psychophysiology of yoga and its applications (pp. 24–48). IGI Global.
Massoumi, L. (2017). The growth of complementary and integrative medicine. In P. L. In Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 1–3). American Psychiatric Association Publishing.
Mathews, J. D., Riley, M. D., Fejo, L., et al. (1988). Effects of the heavy usage of kava on physical health: Summary of a pilot survey in an aboriginal community. Medical Journal of Australia, 148, 548–555.
Mathews, J. M., Etheridge, A. S., Black, S. R., et al. (2002). Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metabolism and Disposition, 30, 1153–1157.
Mendelson, S. D. (2020). Herbal treatment of major depression. CRC Press Taylor & Francis Group.
Meng, X.-Z., Wu, F., Wei, P.-K., et al. (2012). A Chinese herbal formula to improve general psychological status in posttraumatic stress disorder: A randomized placebo-controlled trial on Sichuan earthquake survivors. Evidence-based Complementary and Alternative Medicine, 2012, 691258.
Meseguer, E., Taboada, R., Sanchez, V., et al. (2002). Life-threatening parkinsonism induced by kava-kava. Movement Disorders, 17(1), 195–196.
Miller, L. G. (1998). Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine, 158, 2200–2211.
Miller, J. J., Fletcher, K., & Kabat-Zinn, J. (1995). Three-year follow-up and clinical implications of a mindfulness-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry, 17, 192–200.
Mischoulon, D., Price, L. H., Carpenter, L. L., et al. (2014). A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-l-methionine (SAMe) versus escitalopram in major depressive disorder. Journal of Clinical Psychiatry, 75(4), 370–376.
Miyake, Y., Sasaki, S., Tanaka, K., et al. (2006). Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: The Osaka Maternal and Child Health Study. Journal of Affective Disorders, 96, 133–138.
Miyaoka, T., Furuya, M., Horiguchi, J., et al. (2015a). Efficacy and safety of yokukansan in treatment-resistant schizophrenia: A randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis). Psychopharmacology, 232(1), 155–164.
Miyaoka, T., Furuya, M., Horiguchi, J., et al. (2015b). Efficacy and safety of yokukansan in treatment-resistant schizophrenia: A randomized, multicenter, double-blind, placebo-controlled trial. Evidence-based Complementary and Alternative Medicine, 2015, 1–11.
Miyasaka, L. S., Atallah, A. N., et al. (2007). Passiflora for anxiety disorder. Cochrane Database of Systematic Reviews, (1), CD004518.
Modabbernia, A. (2017). Melatonin and melatonin analogues for psychiatric disorders. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 211–220). American Psychiatric Association Publishing.
Modabbernia, A., & Akhondzadeh, S. (2013). Saffron, passionflower, valerian, and sage for mental health. Psychiatric Clinics of North America, 36(1), 85–92.
Moriyama, T. S., Polanczyk, G., et al. (2012). Evidence-based information on the clinical use of neurofeedback for ADHD. Neurotherapeutics, 9(3), 588–598.
Morris, M. C., Evans, D. A., Bienias, J. L., et al. (2003). Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology, 60, 194–200.
Moshiri, E., Basti, A. A., et al. (2006). Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial. Phytomedicine, 13(9–10), 607–611.
Movafegh, A., Alizadeh, R., et al. (2008). Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: A double-blind, placebo-controlled study. Anesthesia and Analgesia, 106(6), 1728–1732.
Muench, F., & Kumar, D. S. (2017). Using technology-based mind-body tools in clinical practice. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 353–366). American Psychiatric Association Publishing.
Mukai, T., Kishi, T., Mats, Y., et al. (2014). A meta-analysis of inositol for depression and anxiety disorders. Human Psychopharmacology Clinical and Experimental, 29, 55–63.
Muller, S. F., & Klement, S. (2006). A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine, 13, 383–387.
Muller, W. E., Singer, A., Wonnemann, M., et al. (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry, 31(Suppl 1), 16–21.
Murdoch, I., Perry, E. K., Court, J. A., et al. (1998). Cortical cholinergic dysfunction after human head injury. Journal of Neurotrauma, 15, 295–305.
Muskin, P. R. (Ed.). (2000). Complementary and alternative medicine and psychiatry (Review of psychiatry) (Vol. 19). American Psychiatric Press.
Negi, K. S., Singh, Y. D., Kushwaha, K. P., et al. (2000). Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder (Abstract). Indian Journal of Psychiatry, 42(Suppl 2), 4.
Ng, B. Y. (1999). Qigong-induced mental disorders: A review. Australian and New Zealand Journal of Psychiatry, 33, 197–206.
Ng, Q. X., Venkatanarayanan, N., & Ho, C. Y. X. (2017). Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. Journal of Affective Disorders, 210, 211–221.
Nidecker, A. (1997). Probing genes, drugs, and fatty acids in dementia. Clinical Psychiatry News, December, 4.
Nierenberg, A. A., Burt, T., Matthews, J., et al. (1999). Mania associated with St. John’s wort. Biological Psychiatry, 46, 1707–1708.
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., et al. (2006). Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry, 163, 210–216.
Noorbala, A. A., Akhondzadeh, S., Tahmacebi-Pour, N., et al. (2005). Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: A double-blind, randomized pilot trial. Ethnopharmacology, 97(2), 281–284.
Numata, T., Gunfan, S., Takayama, S., et al. (2014). Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: A randomized observer-blinded controlled trial in survivors of the great East Japan earthquake and tsunami. Evidence-Based Complementary and Alternative Medicine, 2014, 683293.
Nyer, M., Gerbarg, P. L., Liveri, M. M., Johnston, J., Scott, T. M., Nauphal, M., Owen, L., Nielsen, G. H., Mischoulon, D., Brown, R. P., Fava, M., & Streeter, C. C. (2018). A randomized controlled dosing study of Iyengar yoga and coherent breathing for the treatment of major depressive disorder: Impact on suicidal ideation and safety findings. Complementary Therapies in Medicine, 37, 136–142.
Otero-Losada, M. E., & Rubio, M. C. (1989a). Acute changes in 5-HT metabolism after S-adenosyl-l-methionine administration. General Pharmacology, 20, 403–406.
Otero-Losada, M. E., & Rubio, M. C. (1989b). Acute effects of S-adenosyl-l-methionine on catecholaminergic central function. European Journal of Pharmacology, 163, 353–356.
Panossian, A., & Amsterdam, D. (2017). Adaptogens in psychiatric practice. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 113–134). American Psychiatric Association Publishing.
Panossian, A., & Wagner, H. (2005). Stimulating effect of adaptogens: An overview with particular reference to their efficacy following single dose administration. Phytotherapy Research, 19, 819–838.
Panossian, A., Wikman, G., et al. (2010). Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine, 17(7), 481–493.
Papakostas, G. I. (2006). Treatment-resistant major depressive disorder: New developments in 2006. Psychiatric Times, 23, 17–20.
Papakostas, G. I., Mischoulon, D., et al. (2010). S-Adenosylmethionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: A double-blind, randomized clinical trial. American Journal of Psychiatry, 167(8), 942–948.
Paul, M. A., Brown, G., Buguet, A., et al. (2001). Melatonin and zopiclone as pharmacologic aids to facilitate crew rest. Aviation, Space, and Environmental Medicine, 72(11), 974–984.
Payne, P., & Crane-Godreau, M. A. (2013). Meditative movement for depression and anxiety. Frontiers in Psychiatry, 4(71), 1–15.
Pearson, N. J., Johnson, L. L., et al. (2006). Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Archives of Internal Medicine, 166(16), 1775–1782.
Peet, M., Brind, J., Ramchand, C. N., et al. (2001). Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophrenia Research, 49(3), 243–251.
Penninx, B. W., Guralnik, J. M., Ferrucci, L., et al. (2000). Vitamin B12 deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women’s Health and Aging Study. American Journal of Psychiatry, 157, 715–721.
Pettegrew, J. W., Levine, J., & McClure, R. J. (2000). Acetyl-l-carnitine physical-chemical, metabolic, and therapeutic properties: Relevance for its mode of action in Alzheimer’s disease and geriatric depression. Molecular Psychiatry, 5, 616–632.
Philippot, P., Gaetane, C., & Blairy, S. (2002). Respiratory feedback in the generation of emotion. Cognition and Emotion, 16, 605–607.
Pilkington, K., Kirkwood, G., et al. (2007). Acupuncture for anxiety and anxiety disorders –a systematic literature review. Acupuncture in Medicine, 25(1–2), 1–10.
Porges, S. W., & Carter, S. S. (2017). Polyvagal theory and the social engagement system. Neurophysiological bridge between connectedness and health. In P. L. Gerbarg, O. R. Muskin, & R. P. Brown (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 221–240). American Psychiatric Association Publishing.
Prasad, A. S. (2009). Zinc: Role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition and Metabolic Care, 12(6), 646–652.
Quiñones, N., Maquet, Y. G., Vélez, D. M., et al. (2015). Efficacy of a Satyananda Yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. International Journal of Yoga Therapy, 25(1), 89–99.
Rahimi, R., Nikfar, S., et al. (2009). Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis. Progress in Neuro Psychopharmacology and Biological Psychiatry, 33(1), 118–127.
Raison, C. L., Capuron, L., & Miller, A. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24–31.
Rao, N. P., Varambally, S., & Gangadhar, B. N. (2013). Yoga school of thought and psychiatry: Therapeutic potential. Indian Journal of Psychiatry, 55(Suppl 2), S145–S149.
Reay, J. L., Scholey, A. D., & Kennedy, D. O. (2010). Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Human Psychopharmacology, 25(6), 462–471.
Richardson, A. J. (2006). Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. International Review of Psychiatry, 18, 155–172.
Richter, Y., Herzog, Y., Lifshitz, Y., et al. (2013). The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: A pilot study. Clinical Interventions in Aging, 8, 557–563.
Riggs, K., Spiro, A., III, Tucker, K., et al. (1996). Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition, 63, 306–314.
Ritsner, M. S., Miodownik, C., Ratner, Y., et al. (2011). l-Theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: An 8-week, randomized, double-blind, placebo-controlled, 2-center study. Journal of Clinical Psychiatry, 72(1), 34–42.
Robbins, J. (2000). A symphony in the brain: The evolution of the new brain wave biofeedback. Grove Press.
Romero-Cerecero, O., Islas-Garduño, A. L., Zamilpa, A., et al. (2019). Galphimine-B standardized extract versus alprazolam in patients with generalized anxiety disorder: A ten-week, double-blind, randomized clinical trial. BioMed Research International, 2019, 1037036.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905–1917.
Sakurai, H., Carpenter, L. L., & Tyrka, A. R. (2020). Dose increase of S-Adenosyl-methionine and escitalopram in a randomized clinical trial for major depressive disorder. Journal of Affective Disorders, 262, 118–125.
Salehi, B., Imani, R., et al. (2010). Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: A double blind, randomized controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(1), 76–80.
Salgueiro, J. B., Ardenghi, P., et al. (1997). Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacology, Biochemistry, and Behavior, 58(4), 887–891.
Sanchez-Villegas, A., Henriquez, P., et al. (2007). Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. European Journal of Nutrition, 46(6), 337–346.
Saratikov, A. S., & Krasnov, E. A. (1987a). Effect of Rhodiola rosea on the central nervous system. In A. S. Saratikov & E. A. Krasnov (Eds.), Rhodiola Rosea is a valuable medicinal plant (Golden root) (pp. 150–179). Tomsk State University Press.
Saratikov, A. S., & Krasnov, E. A. (1987b). Clinical studies of Rhodiola. In A. S. Saratikov & E. A. Krasnov (Eds.), Rhodiola Rosea is a valuable medicinal plant (Golden root) (pp. 216–227). Tomsk State University Press.
Sarris, J. (2012). Current challenges in appraising complementary medicine evidence. Medical Journal of Australia, 196(5), 310–311.
Sarris, J. (2013a). Ginkgo. In K. Bone & S. Mills (Eds.), Principles and practice of phytotherapy (2nd ed.). Churchill Livingstone Elsevier.
Sarris, J. (2013b). St John’s wort for the treatment of psychiatric disorders. Psychiatric Clinics of North America, 36(1), 65–72.
Sarris, J., & Byrne, G. J. (2011). A systematic review of insomnia and complementary medicine. Sleep Medicine Reviews, 15(2), 99–106.
Sarris, J., Kavanagh, D. J., Byrne, G., et al. (2009a). The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology, 205(3), 399–407.
Sarris, J., Kavanagh, D. J., & Byrne, G. (2009b). Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. Journal of Psychiatric Research, 44(1), 32–41.
Sarris, J., Schoendorfer, N., et al. (2009c). Major depressive disorder and nutritional medicine: A review of monotherapies and adjuvant treatments. Nutrition Reviews, 67(3), 125–131.
Sarris, J., Kean, J., Schweitzer, I., et al. (2011a). Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): A systematic review of the evidence. Complementary Therapies in Medicine, 19(4), 216–227.
Sarris, J., LaPorte, E., & Schweitzer, I. (2011b). Kava: A comprehensive review of efficacy, safety, and psychopharmacology. Australian and New Zealand Journal of Psychiatry, 45(1), 27–35.
Sarris, J., Fava, M., et al. (2012a). St. John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: Continuation data from a 26 week RCT. Pharmacopsychiatry, 45(7), 275–278.
Sarris, J., Mischoulon, D., et al. (2012b). Omega-3 for bipolar disorder: Meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry, 73(1), 81–86.
Sarris, J., Glick, R., Hoenders, R. J., et al. (2013a). Integrative mental healthcare White Paper: Establishing a new paradigm through research, education, and clinical guidelines. Advances in Integrative Medicine, 1(1), 9–16.
Sarris, J., McIntyre, E., & Carnfield, D. A. (2013b). Plant-based medicines for anxiety disorders. Part 2: A systematic review of clinical studies with supporting preclinical evidence. CNS Drugs, 27(4), 301–319.
Sarris, J., Nierenberg, A. A., Schweitzer, I., et al. (2013c). Conditional probability of response or nonresponse of placebo compared with antidepressants or St John’s wort in major depressive disorder. Journal of Clinical Psychopharmacology, 33(6), 827–830.
Sarris, J., Stough, C., et al. (2013d). Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 33(5), 643–648.
Sarris, J., Papakostas, G., & Vitelos, et al. (2014). S-Adenosylmethionine (SAMe) versus escitalopram and placebo in major depression: Efficacy and effects of histamine and carnitine as moderators of response. Journal of Affective Disorders, 164, 76–81.
Sarris, J., Oliver, G., Camfield, D. A., et al. (2015). N-acetyl cysteine (NAC) in the treatment of obsessive-compulsive disorder: A 16-week, double-blind, randomised, placebo-controlled study. CNS Drugs, 29(9), 801–809.
Sarris, J., Byrne, G. J., Stough, C., et al. (2019a). Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial. Journal of Affective Disorders, 245, 1007–1015.
Sarris, J., Byrne, G. J., Bousman, C. A., et al. (2019b). Kava for generalised anxiety disorder: A 16-week double-blind, randomized, placebo-controlled study. The Australian and New Zealand Journal of Psychiatry, 54(3), 288–229.
Sarris, J., Murphey, S. C., et al. (2020). S-Adenosylmethionine (SAMe) monotherapy for depression: An 8-week double-blind, randomised, controlled trial. Psychopharmacology, 237(1), 209–218.
Sarris, J., Wolfgang, M., Ashton, M. M., et al. (2021). Plant-based medicines (Phytoceuticals) in the treatment of psychiatric disorders: A meta-review of meta-analyses of randomized controlled trials. The Canadian Journal of Psychiatry (in press).
Satyanarayana, M., Rajeswari, K. R., Rani, N. J., et al. (1992). Effect of Santhi Kriya on certain psychophysiological parameters: A preliminary study. Indian Journal of Physiology and Pharmacology, 36(2), 88–92.
Schardt, D. (2000). St. John’s worts and all. Nutrition Action Healthletter, September, 6–8.
Schaumburg, H. H., & Berger, A. (1992). Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. JAMA, 268, 3430–3431.
Schefft, C., Kilarski, L. L., Bschor, T., et al. (2017). Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis. European Neuropsychopharmacology, 27(11), 1090–1109.
Schellenberg, R., Sauer, S., & Dimpfel, W. (1998). Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry, 31(Suppl 1), 44–53.
Schmidt, M., Betti, G., & Hensel, A. (2007). Saffron in phytotherapy: Pharmacology and clinical uses. Wiener Medizinische Wochenschrift, 157(13–14), 315–319.
Scholey, A. B., Tildesley, N. T., Ballard, C. G., et al. (2008). An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology, 198(1), 127–139.
Scholey, A., Ossoukhova, A., Owen, L., Ibarra, A., Pipingas, A., He, K., Roller, M., & Stough, C. (2010). Effects of American ginseng (Panax quinquefolius) on neurocognitive function: An acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology, 212(3), 345–356. https://doi.org/10.1007/s00213-010-1964-y. Epub 2010 Jul 31. PMID: 20676609; PMCID: PMC2952762.
Schweitzer, I., Maguire, K., et al. (2009). Sexual side-effects of contemporary antidepressants: Review. Australian and New Zealand Journal of Psychiatry, 43(9), 795–808.
Scuteri, D., Morrone, L. A., Rombola, L., et al. (2017). Aromatherapy and aromatic plants for the treatment of behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease: Clinical evidence and possible mechanisms. Evidence-based Complementary and Alternative Medicine, 2017, 1–30.
Seshadri, A., Adaji, A., Orth, S. S., et al. (2020). Exercise, Yoga, and Tai Chi for treatment of major depressive disorder in outpatient settings: A systematic review and meta-analysis. Primary Care Companion Central Nervous System Disorders, 23(1), 20r02722.
Shakibaei, F., Radmanesh, M., Salari, E., et al. (2015). Ginkgo biloba in the treatment attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled trial. Complementary Therapies in Clinical Practice, 21(2), 61–67.
Shamir, E., Laudon, M., Barak, Y., et al. (2000). Melatonin improves sleep quality of patients with chronic schizophrenia. Journal of Clinical Psychiatry, 61, 373–377.
Sharma, A., Gerbarg, P., Bottiglieri, T., et al. (2017). S-Adenosylmethionine (SAMe) for neuropsychiatric disorders: A clinician-oriented review of research. Journal of Clinical Psychiatry, 78(6), e656–e667.
Shaw, K., Turner, J., & Del Mar, C. (2002). Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis. Australian and New Zealand Journal of Psychiatry, 36(4), 488–491.
Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., et al. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2–3), 95–105.
Shimada, Y., Arai, T., Tamaoka, A., et al. (2017). Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: Identification of the risk factors in a retrospective cohort study. BMJ Open, 7, e014218.
Shimada, Y., Fujimioto, M., Nogami, T., et al. (2019). Adverse events associated with ethical Kampo formulations: Analysis of domestic adverse-event data reports of the Ministry of Health, Labor, and Welfare in Japan. Evidence-based Complementary and Alternative Medicine, 2019, 1–14, 1643804.
Shinjyo, N., Waddell, G., & Green, J. (2020). Valerian root in treating sleep problems and associated disorders-a systematic review and meta-analysis. Journal of Evidence Based Integrative Medicine, 25, 2515690X20967323.
Singh, Y. N., & Devkota, A. K. (2003). Aqueous kava extracts do not affect liver function tests in rats. Planta Medica, 69, 496–499.
Singh, S. P., & Singh, V. (2011). Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs, 25(10), 859–885.
Singh, S. P., Telles, S., & Balkrishna. (2017). Use of yoga in managing posttraumatic stress disorder. In P. L. Gerbarg, R. P. Brown, & P. R. Muskin (Eds.), Complementary and integrative treatments in psychiatric practice (pp. 251–260). American Psychiatric Association Publishing.
Sinn, N., & Bryan, J. (2007). Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. Journal of Developmental and Behavioral Pediatrics, 28(2), 82–91.
Small, G. W., Siddarth, P., Zhaoping, L., et al. (2018). Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: A double-blind placebo-controlled 18-month trail. American Journal of Geriatric Psychiatry, 23(3), 266–277.
Smith, A. D., Smith, A. M., & de Jager, C. A. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One, 5(9), e12244.
Smith, R. C., Boules, S., Maayan, L., et al. (2013). Effects of yoga on cognition, psychiatric symptoms, and epigenetic changes in chronic schizophrenic patients. Presented at the 14th international schizophrenia congress, Orlando, FL, 22 April 2013.
Smith, C. A., Armour, M., Lee, M. S., et al. (2018). Acupuncture for depression (review). Cochrane Database of Systematic Reviews, 3(3), CD004046.
Soares-Weiser, K., Maayan, N., & Bergman, H. (2018). Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews, (1), CD000209.
Sonuga-Barke, E. J., Brandeis, D., Cortese, S., et al. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170(3), 275–289.
Sorensen, H., & Sonne, J. (1996). A double-masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research, 57, 959–968.
Stevens, L. J., Zentall, S. S., Deck, J. L., et al. (1995). Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition, 62, 761–768.
Stevenson, J., Sonuga-Barke, E., McCann, D., et al. (2010). The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children’s ADHD symptoms. American Journal of Psychiatry, 167(9), 1108–1115.
Stratyner, H. B. (2006). Multi-factorial approaches to substance use disorders and addiction. CNS Spectrums, 11, 828.
Streeter, C. C., Gerbarg, P. L., Saper, R. B., et al. (2012). Effects of yoga on the autonomic nervous system, gamma-aminobutyric acid, and allostasis in epilepsy, depression, and posttraumatic stress disorder. Medical Hypotheses, 78(5), 571–579.
Streeter, C. C., Gerbarg, P. L., Brown, R. P., et al. (2020a). Thalamic gamma aminobutyric acid level changes in major depressive disorder after a 12-week Iyengar yoga and coherent breathing intervention. Journal of Alternative and Complementary Medicine, 26(3), 190–197.
Streeter, C. C., Gerbarg, P. L., Nyer, M. B., et al. (2020b). Yoga: Part of a treatment plan for uncontrolled epilepsy. Journal of Neurological Disorders and Stroke, 7(1), 1156–1162.
Suhner, A., Schlagenhauf, P., Johnson, R., et al. (1998). Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiology International, 15(6), 655–666.
Szegedi, A., Kohnen, R., Dienel, A., et al. (2005). Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): Randomised controlled double blind non-inferiority trial versus paroxetine. BMJ, 330, 503.
Szewczyk, B., Kubera, M., et al. (2011). The role of zinc in neurodegenerative inflammatory pathways in depression. Progress in Neuro Psychopharmacology and Biological Psychiatry, 35(3), 693–701.
Takeda, A. (2011). Zinc signaling in the hippocampus and its relation to pathogenesis of depression. Molecular Neurobiology, 44(2), 166–174.
Targum, S. D., Cameron, B. R., & Ferreira, et al. (2018). An augmentation study of MSI-195 (S-adenosylmethionine) in major depressive disorder. Journal of Psychiatric Research, 107, 86–96.
Telles, S., & Singh, N. (2013). Science of the mind: Ancient yoga texts and modern studies. Psychiatric Clinics of North America, 36(1), 93–108.
Telles, S., Nagarathna, R., Nagendra, H. R., et al. (1993). Physiological changes in sports teachers following 3 months of training in yoga. Indian Journal of Medical Science, 47(10), 235–238.
Teschke, R., Sarris, J., et al. (2011). Kava, the anxiolytic herb: Back to basics to prevent liver injury? British Journal of Clinical Pharmacology, 71(3), 445–448.
Thiele, B., Brink, I., & Ploch, M. (1994). Modulation of cytokine expression by hypericum extract. Journal of Geriatric Psychiatry and Neurology, 7(Suppl 1), S60–S62.
Tildesley, N. T., Kennedy, D. O., Perry, E. K., et al. (2005). Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology and Behavior, 83(5), 699–709.
Tolahunase, M., Sager, R., Faiq, M., et al. (2018a). Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. Restorative Neurology and Neuroscience, 36(3), 423–442.
Tolahunase, M., Sager, R., Dada, R., et al. (2018b). 5-HTTLPR and MTHFR 677C>T polymorphisms and response to a yoga-based lifestyle intervention in major depressive disorder: A randomized active-controlled trial. Indian Journal of Psychiatry, 60(4), 410–426.
Torrioli, M. G., Vernacotola, S., et al. (2008). A double-blind, parallel, multicenter comparison of l-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. American Journal of Medical Genetics, Part A, 146(7), 803–812.
Torta, R., Zanalda, F., Rocca, P., et al. (1988). Inhibitory activity of S-adenosyl-l-methionine on serum gamma-glutamyl-transpeptidase increase induced by psychodrugs and anticonvulsants. Current Therapeutic Research, 44, 144–159.
Trebatická, J., Kopasova, S., Hradecna, Z., et al. (2006). Treatment of ADHD with French maritime pine bark extract, pycnogenol. European Child and Adolescent Psychiatry, 15, 329–335.
Tsang, H. W., Fung, K. M., Chan, A. S., et al. (2006). Effect of a qigong exercise programme on elderly with depression. International Journal of Geriatric Psychiatry, 21(9), 890–897.
US Department of Health and Human Services Agency for Healthcare Research and Quality. (2002). S-Adenosyl-l-methionine for treatment of depression, osteoarthritis, and liver disease. Evidence report/technology assessment no. 64. https://www.ncbi.nlm.nih.gov/books/NBK11886/. Accessed 17 Feb 2022.
Vaisman, N., Kaysar, N., & Zaruk-Adasha, Y. (2008). Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: Effect of dietary n-3 fatty acids containing phospholipids. American Journal of Clinical Nutrition, 87(5), 1170–1180.
Vancampfort, D., Stubbs, B., Van Damme, T., et al. (2021). The efficacy of meditation-based mind-body interventions for mental disorders: A meta-review of 17 meta-analyses of randomized controlled trials. Journal of Psychiatric Research, 134, 181–191.
Varambally, S., Gangadhar, B. N., Thirthalli, J., et al. (2012). Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist. Indian Journal of Psychiatry, 54, 227–232.
Varteresian, T., & Lavretsky, H. (2018). Complementary and integrative therapies in psychiatry. Focus, 16(1), 54–56.
Vaschillo, E., Vaschillo, B., & Lehrer, P. (2004). Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest, 126, 1385–1386.
Vellas, B., Coley, N., Ousset, P. J., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurology, 11(10), 851–859.
Visceglia, E. (2007). Healing mind and body: Using therapeutic yoga in the treatment of schizophrenia. International Journal of Yoga Therapy, 17, 95–102.
Visceglia, E., & Lewis, S. (2011). Yoga therapy as an adjunctive treatment for schizophrenia: A randomized, controlled pilot study. Journal of Alternative and Complementary Medicine, 17, 601–607.
Voelker, R. (1999). Herbs and anethesia. JAMA, 281, 1882.
Vorbach, E. U., Arnoldt, K. H., & Hubner, W. D. (1997). Efficacy and tolerability of St. John’s wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry, 30(Suppl 2), 81–85.
Vuong, Q. V., Bowyer, M. C., et al. (2011). l-Theanine: Properties, synthesis and isolation from tea. Journal of the Science of Food and Agriculture, 91(11), 1931–1939.
Wang, S. M., Kain, Z. N., et al. (2008). Acupuncture analgesia: I. The scientific basis. Anesthesia and Analgesia, 106(2), 602–610.
Wang, C., Li, K., Seo, D.-C., et al. (2020). Use of complementary and alternative medicine in children with ADHD: Results from the 2012 and 2017 National Health Interview Survey. Complementary Therapies in Medicine, 49, 102352.
Weber, W., Vander Stoep, A., et al. (2008). Hypericum perforatum (St John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents: A randomized controlled trial. JAMA, 299(22), 2633–2641.
White, D. J., Camfield, D. A., Ossoukhova, A., Savage, K., Le Cozannet, R., Fança-Berthon, P., & Scholey, A. (2020). Effects of Panax quinquefolius (American ginseng) on the steady state visually evoked potential during cognitive performance. Human Psychopharmacology, 35(6), 1–6. https://doi.org/10.1002/hup.2756. Epub 2020 Sep 8. PMID: 32896022; PMCID: PMC7685123.
Whitten, D., Myers, D., et al. (2006). The effect of St John’s wort extracts on CYP3A: A systematic review of prospective clinical trials. British Journal of Clinical Pharmacology, 62(5), 512–526.
Willatts, P., Forsyth, J. S., DiModugno, M. K., et al. (1998). Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. The Lancet, 352, 688–691.
Williams, A. L., Katz, D., et al. (2006). Do essential fatty acids have a role in the treatment of depression? Journal of Affective Disorders, 93(1–3), 117–123.
Yang, X.-Y., Yang, N.-B., & Huang, F. F. (2021). Effectiveness of acupuncture on anxiety disorder: A systematic review and meta-analysis of randomised controlled trials. Annals of General Psychiatry, 20(9), 1–14.
Yary, T., & Aazami, S. (2012). Dietary intake of zinc was inversely associated with depression. Biological Trace Element Research, 145(3), 286–290.
Yeung, W. F., Chung, K. F., & Leung, Y. K. (2009). Traditional needle acupuncture treatment for insomnia: A systematic review of randomized controlled trials. Sleep Medicine, 10(7), 694–704.
Yolland, C. O., Phillipou, A., & Castle, D. (2020). Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review. Nutrition Neuroscience, 23(2), 139–148.
Youdim, K. A., Martin, A., & Joseph, J. A. (2000). Essential fatty acids and the brain: Possible health implications. International Journal of Developmental Neuroscience, 18, 383–399.
Zaccaro, A., Piarulli, A., Laurino, M., et al. (2018). How breath-control can change your life: A systematic review on psycho-physiological correlates of slow breathing. Frontiers in Human Neuroscience, 12, 353–369.
Zanardi, R., & Smeraldi, E. (2006). A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia. European Neuropsychopharmacology, 16, 281–287.
Zandi, P. P., Anthony, J. C., Khachaturian, A. S., et al. (2004). Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Archives of Neurology, 61, 82–88.
Zhang, X. Y., Zhou, D. F., Zhang, P. Y., et al. (2001). A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. Journal of Clinical Psychiatry, 62, 878–883.
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., et al. (2001). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology and Metabolism, 86, 4727–4730.
Zhou, Y., Hou, Y., Shen, J., et al. (2020). A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biology, 18(11), e3000970.
Zylowska, L. (2012). The mindfulness prescription for adult ADHD. Trumpeter Books.
Acknowledgments
Prof Jerome Sarris is funded by an Australian National Health & Medical Research Council fellowship (NHMRC funding ID 1125000).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Sarris, J., Gerbarg, P.L., Brown, R.P., Muskin, P.R. (2023). Integrative and Complementary Medicine in Psychiatry. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_145-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-42825-9_145-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42825-9
Online ISBN: 978-3-030-42825-9
eBook Packages: Springer Reference MedicineReference Module Medicine